ARTICLE
19 September 2016

FDA Issues Infant Formula Draft Guidance

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On September 8, 2016, FDA issued draft guidance "Substantiation for Structure/Function Claims in Infant Formula Labels and Labeling."
United States Food, Drugs, Healthcare, Life Sciences

On September 8, 2016, FDA issued draft guidance "Substantiation for Structure/Function Claims in Infant Formula Labels and Labeling." The guidance describes the type and quality of evidence that is appropriate to substantiate claims about effects on the structure or function of the body (i.e., supports digestion) made on the label and in other labeling of nonexempt and exempt infant formulas, which are defined as "a food which purports to be or is represented for special dietary use solely as a food for infants [a person not more than 12 months old] by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk." FDA does not preapprove structure/function claims in the labeling of infant formulas. However, FDA stated these claims need to be substantiated by "competent and reliable scientific evidence" as "this vulnerable population is entirely dependent upon caregivers who must be able to trust that the information on the label is truthful and scientifically supported."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More